May Edition - 2026

May Edition - 2026

India Pharma Outlook’s May Edition - 2026: The edition has been prepared after being closely scrutinized by a distinguished panel of judges including CXOs, analysts, and our editorial board. We recognize their valuable contribution to the ever expanding and competitive market and their ability to sustain themselves and emerge as top contestants through their reliable products.

"By leveraging automation and digital systems, Higer not only enhances productivity but also ensures faster turnaround times, an essential factor in today’s fast-paced market environment" Higer Health Sciences

"By collaborating with more than 20 manufacturing partners across therapeutic areas and dosage forms, Humaniqe Biopharmaceuticals ensures product availability and flexibility. This multi-partner model eliminates dependency on a single manufacturer and allows Humaniqe to cater to diverse market requirements efficiently" - Humaniqe Biopharmaceuticals

"At INNDEVICE, our purpose is to research & revolutionize best in-class patient-centric medical devices. Our vision is to redefine healthcare and identify ourselves as a pioneer in creating best solutions for medical challenges. Our mission is to innovate or guide or collaborate with medical technology and pharmaceutical industries to empathetically develop unique, next generation, patient-centric medical devices. These key pillars have shaped our direction,...

May Edition - 2026

InnDevice InnDevice InnDevice The global landscape for medical devices and drug-device combination products is not just evolving, but shaping the way healthcare is delivered across the world.
Higer Health Sciences Higer Health Sciences Higer Health Sciences The nutraceutical and health supplement industry has witnessed a remarkable transformation over the past decade, evolving from a niche wellness segment into a cornerstone of preventive healthcare.

© 2026 India Pharma Outlook. All Rights Reserved.